Talk:SARS-CoV-2 Delta variant: Difference between revisions
Appearance
Content deleted Content added
m Signing comment by 91.153.64.166 - "→Delta plus: nu" |
m remove deprecated parameters from talk header |
||
(31 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{Talk page header |
{{Talk page header}} |
||
{{WikiProject banner shell|collapsed=yes |class=C| |
|||
⚫ | |||
{{WikiProject |
{{WikiProject COVID-19 |importance=High}} |
||
{{WikiProject Medicine |importance=Mid |pulmonology=yes |pulmonology-imp=high |society=yes |society-imp=high |emergency=yes |emergency-imp=Mid}} |
|||
{{WikiProject COVID-19 |class=C |importance=High}} |
|||
{{WikiProject |
{{WikiProject Molecular Biology |importance=Low|genetics=yes}} |
||
{{WikiProject |
{{WikiProject Viruses |importance=Mid}} |
||
{{WikiProject |
{{WikiProject India |importance=Low}} |
||
{{WikiProject |
{{WikiProject Disaster management |importance=Low}} |
||
{{WikiProject India |class=C |importance=Low}} |
|||
{{WikiProject Disaster management |class=C |importance=Low}} |
|||
}} |
}} |
||
⚫ | |||
{{annual readership}} |
{{annual readership}} |
||
{{User:MiszaBot/config |
{{User:MiszaBot/config |
||
Line 20: | Line 20: | ||
| minthreadsleft = 2 |
| minthreadsleft = 2 |
||
}} |
}} |
||
{{dashboard.wikiedu.org assignment | course = Wikipedia:Wiki_Ed/York_College_of_Pennsylvania/Technical_and_Scientific_Communication_(Fall_2021) | assignments = [[User:Aweger|Aweger]] | start_date = 2021-08-23 | end_date = 2021-12-10 }} |
|||
== Incomplete sentence? == |
|||
The sentence "These fatality rates are lower than the average fatality rate of 1.9%, presumably due to the now relative high percentage of the more vulnerable in England." seems incomplete. Is something like "... that have been vaccinated." missing at the end? |
|||
== study https://www.medrxiv.org/content/10.1101/2021.08.08.21261768v1.article-metrics == |
|||
When it says "On August 10, a study showed that the full vaccination coverage rate is correlated inversely to the SARS-CoV-2 delta variant mutation frequency in 16 countries (R-squared=0.878). Data strongly indicates that full vaccination against COVID-19 is critical to suppress emergent mutations.[68]" |
|||
This study is a PREPRINT and the statistic analysis isn't rigorous because it violates some assumptions and it has some issues not addressed by the researcher. |
|||
== Covid Delta Variants: New Cases Rising and being ignored by poliitcs == |
|||
New Delta Cases are on the rise as Politics within Europe are ignoring it. It has shown that the mutated variant has spread up to 85% within the last 2-3 months. Politics within central Europe seem to ignore such data and are reopening Bars, Restaurants and normal life continues, but at what cost? |
|||
The Delta Variant shows that hospitalization rate increases by 63% for not Vaccinated people and therefore is considered as extremely dangerous. People who have only received one vaccine shot are likely to decease by 23% and has been proven to be irrelevant for politics. <!-- Template:Unsigned --><span class="autosigned" style="font-size:85%;">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[User:Hallomynameistom|Hallomynameistom]] ([[User talk:Hallomynameistom#top|talk]] • [[Special:Contributions/Hallomynameistom|contribs]]) 08:23, 22 October 2021 (UTC)</span> <!--Autosigned by SineBot--> |
|||
== Sentence fragment in virulence section == |
|||
The end of the virulence section has a period where there shouldn't be one. It would appear someone accidentally cut out a part of a sentence/merged two sentences together, maybe someone whose first language isn't English. Hope someone can fix this.--[[User:Phil of rel|Phil of rel]] ([[User talk:Phil of rel|talk]]) 03:01, 25 October 2021 (UTC) |
|||
== What order are the countries in, in the "Statistics" section? == |
|||
What order are the countries in, in the "Statistics" section? Are they supposed to be in order of the number of cases?? Or is there some secondary explanation for why they don't fully seem to be? <small>[[User:Paintspot|Paintspot Infez]] ([[User talk:Paintspot|talk]])</small> 16:23, 26 October 2021 (UTC) |
|||
== Delta-specific covid vaccine trial results == |
|||
I googled: |
|||
delta-specific covid vaccine trial |
|||
* November 1, 2021: |
|||
'''Moderna''' is investigating the usefulness of Delta-specific booster, hoping to post trial results in '''early 2022'''. |
|||
https://www.businessinsider.com/delta-booster-unlikely-data-experts-suggest-unnecessary-2021-10?r=US&IR=T |
|||
* September 29, 2021: |
|||
'''Pfizer'''/BioNTech is testing out a reformulated vaccine candidate specifically targeting delta. Clinical trial results are anticipated in the '''fourth quarter''' of the year. |
|||
https://www.advisory.com/daily-briefing/2021/09/29/delta-booster |
|||
* No results posted yet: |
|||
https://investors.modernatx.com/news-releases |
|||
--[[User:Ee1518|ee1518]] ([[User talk:Ee1518|talk]]) 22:50, 1 November 2021 (UTC) |
|||
== Delta plus == |
|||
https://uk.news.yahoo.com/thousands-cases-delta-plus-variant-confirmed-uk-135828311.html found in 33 countries. The article at present is not very clear on this name delta plus - several variants seem to have the name. It seems the most used name now is AY 4.2 and that there are 2 significant spike protein mutations in this variant i.e. A222V and Y145H. - this name usage could be made clearer. https://www.newsweek.com/ay-4-2-variant-covid-spread-faster-unknown-sequencing-issues-1645386 <!-- Template:Unsigned IP --><small class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/91.153.64.166|91.153.64.166]] ([[User talk:91.153.64.166#top|talk]]) 03:16, 10 November 2021 (UTC)</small> <!--Autosigned by SineBot--> |
|||
It is also suggested the name could be nu https://insiderpaper.com/ay-4-2-up-to-15-more-transmissible-than-delta-may-be-named-nu/ - this has not happened yet. <!-- Template:Unsigned IP --><small class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/91.153.64.166|91.153.64.166]] ([[User talk:91.153.64.166#top|talk]]) 03:30, 10 November 2021 (UTC)</small> <!--Autosigned by SineBot--> |
Latest revision as of 03:50, 11 October 2024
This is the talk page for discussing improvements to the SARS-CoV-2 Delta variant article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 30 days |
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to multiple WikiProjects. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
Categories:
- C-Class COVID-19 articles
- High-importance COVID-19 articles
- WikiProject COVID-19 articles
- C-Class medicine articles
- Mid-importance medicine articles
- C-Class emergency medicine and EMS articles
- Mid-importance emergency medicine and EMS articles
- Emergency medicine and EMS task force articles
- C-Class society and medicine articles
- High-importance society and medicine articles
- Society and medicine task force articles
- C-Class pulmonology articles
- High-importance pulmonology articles
- Pulmonology task force articles
- All WikiProject Medicine pages
- C-Class Molecular Biology articles
- Low-importance Molecular Biology articles
- C-Class Genetics articles
- Low-importance Genetics articles
- WikiProject Genetics articles
- All WikiProject Molecular Biology pages
- C-Class virus articles
- Mid-importance virus articles
- WikiProject Viruses articles
- C-Class India articles
- Low-importance India articles
- C-Class India articles of Low-importance
- WikiProject India articles
- C-Class Disaster management articles
- Low-importance Disaster management articles